Funding Announcement: Carisma Closes $53 Million Series A Financing

June 27, 2018

Carisma Therapeutics closes a $53 Million Series A financing with top investors to develop novel CAR-Macrophage immunotherapies and announces the members of its inaugural Scientific Advisory Board.